AP
GILD icon

Alydar Partners’s Gilead Sciences GILD Stock Holding History

Alydar Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-640,000
Closed -$40.2M – 104
2013
Q3 		$40.2M Sell
640,000
-660,000
-51% -$39.4M 3.34% 4
2013
Q2 		$66.7M Buy
+1,300,000
New +$67.8M 3.59% 4

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alydar Partners's GILD Position: Q4 2014 in Review

Alydar Partners sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 100,000 shares — an estimated $10.6M sold.

Alydar Partners first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $75.9M in Q2 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Alydar Partners reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Alydar Partners sold 100,000 Gilead Sciences shares in Q4 2014, an estimated $10.6M.
  • Alydar Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
  • Alydar Partners's Gilead Sciences position peaked at $75.9M in Q2 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Alydar Partners's 13F filing for Q4 2014, filed 17 Feb 2015.